Analysts Estimate Report : What to Look Out for Houston American Energy (NYSEAMERICAN:HUSA)

Earnings results for Houston American Energy (NYSEAMERICAN:HUSA)

Houston American Energy Corporation is estimated to report earnings on 03/12/2021. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date.

Analyst Opinion on Houston American Energy (NYSEAMERICAN:HUSA)

Dividend Strength: Houston American Energy (NYSEAMERICAN:HUSA)

Houston American Energy does not currently pay a dividend. Houston American Energy does not have a long track record of dividend growth.

Insiders buying/selling: Houston American Energy (NYSEAMERICAN:HUSA)

In the past three months, Xeris Pharmaceuticals insiders have sold 40.89% more of their company’s stock than they have bought. Specifically, they have bought $40,600.00 in company stock and sold $57,200.00 in company stock. Only 6.12% of the stock of Xeris Pharmaceuticals is held by insiders. 69.33% of the stock of Xeris Pharmaceuticals is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Earnings and Valuation of Houston American Energy (NYSEAMERICAN:HUSA

Earnings for Xeris Pharmaceuticals are expected to grow in the coming year, from ($2.57) to ($1.84) per share. The P/E ratio of Xeris Pharmaceuticals is -1.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Xeris Pharmaceuticals is -1.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Xeris Pharmaceuticals has a P/B Ratio of 8.91. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

More latest stories: here